Viewing Study NCT01621256


Ignite Creation Date: 2025-12-24 @ 11:19 PM
Ignite Modification Date: 2026-01-05 @ 2:51 AM
Study NCT ID: NCT01621256
Status: COMPLETED
Last Update Posted: 2018-12-21
First Post: 2012-06-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy, Safety, and Tolerability of Ancrod in Patients With Sudden Hearing Loss
Sponsor: Nordmark Arzneimittel GmbH & Co. KG
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hearing Loss View
None Deafness View
None Hearing Loss, Sensorineural View
None Hearing Disorders View
None Ear Diseases View
Keywords: